These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 22139075)
1. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Cronan MR; Nakamura K; Johnson NL; Granger DA; Cuevas BD; Wang JG; Mackman N; Scott JE; Dohlman HG; Johnson GL Oncogene; 2012 Aug; 31(34):3889-900. PubMed ID: 22139075 [TBL] [Abstract][Full Text] [Related]
2. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. Kesavan K; Lobel-Rice K; Sun W; Lapadat R; Webb S; Johnson GL; Garrington TP J Cell Physiol; 2004 Apr; 199(1):140-8. PubMed ID: 14978743 [TBL] [Abstract][Full Text] [Related]
3. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742 [TBL] [Abstract][Full Text] [Related]
4. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940 [TBL] [Abstract][Full Text] [Related]
5. MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Sun W; Wei X; Kesavan K; Garrington TP; Fan R; Mei J; Anderson SM; Gelfand EW; Johnson GL Mol Cell Biol; 2003 Apr; 23(7):2298-308. PubMed ID: 12640115 [TBL] [Abstract][Full Text] [Related]
6. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer. Huang HL; Chiang CH; Hung WC; Hou MF Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171 [TBL] [Abstract][Full Text] [Related]
7. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Castro NE; Lange CA Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930 [TBL] [Abstract][Full Text] [Related]
8. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling. Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580 [TBL] [Abstract][Full Text] [Related]
9. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. Nakamura K; Johnson GL J Biol Chem; 2003 Sep; 278(39):36989-92. PubMed ID: 12912994 [TBL] [Abstract][Full Text] [Related]
10. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W; Liao QY; Hantash FM; Sanders BG; Kline K Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways. Li G; Lucas JJ; Gelfand EW Cell Immunol; 2005 Nov; 238(1):10-8. PubMed ID: 16430878 [TBL] [Abstract][Full Text] [Related]
12. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. Wu W; Pew T; Zou M; Pang D; Conzen SD J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693 [TBL] [Abstract][Full Text] [Related]
14. Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. Chen W; White MA; Cobb MH J Biol Chem; 2002 Dec; 277(51):49105-10. PubMed ID: 12351623 [TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer. Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883 [TBL] [Abstract][Full Text] [Related]
16. MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells. Mirza AA; Kahle MP; Ameka M; Campbell EM; Cuevas BD Biochim Biophys Acta; 2014 May; 1843(5):945-54. PubMed ID: 24491810 [TBL] [Abstract][Full Text] [Related]
17. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival. Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725 [TBL] [Abstract][Full Text] [Related]
18. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells. Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274 [TBL] [Abstract][Full Text] [Related]